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Purpose: To investigate the genotype and phenotype of juvenile-onset open angle glaucoma (JOAG) in a Chinese family
(PN pedigree).
Methods:  Each  family  member  was  comprehensively  examined  by  an  experienced  ophthalmologist.  The  clinical
characteristics of the family patients with JOAG were documented. Blood samples were obtained from 22 available
participants from the PN pedigree. Linkage analysis was performed to identify the possible chromosome loci. The presence
of gene mutation was ascertained by polymerase chain reaction amplification and subsequent direct sequencing.
Results: The affected members in the PN pedigree are characterized by early age of onset (mean age at diagnosis is 17
years old), severe clinical presentations, high intraocular pressure (mean IOP of 34.18±2.97 mmHg), and poor response
to pharmacological treatment (87.5% of the patients required filtering surgery). The region on chromosome 1 between
D1S3464 and D1S1619 was identified in this pedigree by linkage analysis. A Pro370Leu myocilin mutation resulting
from a heterozygous C→T transition at the 1,109th nucleotide in exon 3 was detected by gene sequencing. The Pro370Leu
mutation co-segregated among all affected individuals of PN pedigree.
Conclusions: The GLC1A Pro370Leu mutation is firmly correlated with a severe POAG phenotype. These data provide
clues for the severe disease-causing nature of the Pro370Leu allele. Gene screening may be a useful method for pre-
symptom diagnosis and a forewarning to detect the at-risk individuals in familial open-angle glaucoma patients, especially
in pedigrees of early-onset.
Glaucoma, one of the leading causes of blindness, is a
chronic neurodegenerative disease that affects over 60 million
people worldwide by 2010 [1]. Primary open-angle glaucoma
(POAG), the most common form, is characterized by painless,
progressive, irreversible degeneration of the optic nerve and
loss of visual field [2]. Juvenile glaucoma is a relatively rare
form of primary open-angle glaucoma that occurs in children
and young adults. The exact age of the cut-off between adult-
onset and juvenile-onset disease usually falls between 35 and
40 years of age.
Although the underlying etiology is unknown, there is
evidence that POAG is a complex heterogeneous disease.
According to an epidemiological survey, about 30%–56% of
patients with POAG and ocular hypertension (OHT) have a
family history, and the incidence in individuals with a first
degree relative having glaucoma is about 7–10 times higher
than in the general population [3]. Since the first correlated
mutation  gene  (myocilin)  was  identified  in  1997,  14  loci
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(GLC1A–N) have been linked to POAG [3-5]. Among them,
myocilin  (MYOC),  optineurin  (OPTN),  and  WD  repeat
domain  36  (WDR36)  have  been  identified  as  harboring
causative mutations [5-7].
MYOC  consists  of  three  exons  and  two  introns,  and
encodes a 55–57 kDa protein composed of 504 amino acids.
To  date,  more  than  80  missense  or  nonsense  variants  of
myocilin  have  been  reported  in  different  racial/ethnic
populations, with the majority of them being clustered in the
conserved olfactomedin domain of exon 3 [8]. Myocilin is a
secretary  protein  and  interacts  with  the  components  of
extracellular matrix in trabecular meshwork. The abnormal
function  of  myocilin  has  been  extensively  investigated.
Haploinsufficiency does not appear to be the primary disease
mechanism of MYOC mutations. Current studies demonstrate
that mutant myocilin protein is misfolded and accumulated as
aggregates  in  the  endoplasmic  reticulum,  which  lead  to
dysfunction and apoptosis of trabecular meshwork cells.
Herein,  an  autosomal  dominant  JOAG  family  (PN
pedigree) residing in Guangdong Province of South China
was recruited and subjected to linkage analysis to identify
gene  mutations.  Family  history  of  JOAG  was  thoroughly
recorded, and available family members were examined for
glaucoma. Testing included stereo-optic disc photographs,
Molecular Vision 2011; 17:1449-1456 <http://www.molvis.org/molvis/v17/a163>
Received 31 January 2011 | Accepted 26 May 2011 | Published 1 June 2011
© 2011 Molecular Vision
1449optical coherence tomography, and automated perimetry. The
clinical  features  of  the  pedigree  were  assessed  and  the
correlation  between  the  phenotype  and  the  genotype  was
analyzed.
METHODS
Subjects:  This  study  was  done  in  accordance  with  the
principles of the Declaration of Helsinki. Informed patient
consent  and  approval  by  the  Hospital  Ethics  Committee
(Zhongshan  Ophthalmic  Centre,  Sun  Yat-sen  University,
Guangzhou,  People’s  Republic  of  China)  were  obtained
before initiating the study.
This PN pedigree has three generations and consists of
25 members. The total number of affected individuals was
eight.  Comprehensive  ophthalmologic  examinations  and
general medical history were taken and documented by an
experienced doctor (Zhongshan Ophthalmic Centre, Sun Yat-
sen  University).  The  protocol  included  the  best-corrected
visual acuity using Snellen charts, slit-lamp inspection of the
anterior  eye,  IOP  measurement  by  Goldmann  application
tonometry, anterior chamber angle evaluation by gonioscopy,
and  fundus  examination  including  vertical  and  horizontal
optic  cup  disc  ratio  (C/D  ratio)  assessment.  All  subjects
underwent automated visual field examination (tested with
Humphrey, SITA fast strategy, program 30–2). The Optical
Coherence Tomography (OCT) and color fundus photographs
of the disc and macula were tested to aid with assessment of
the patients’ visual condition and stage of illness.
The diagnosis of POAG was based on an intraocular
pressure  (IOP)  of  22  mmHg  or  higher,  open  angles  on
gonioscopy, glaucomatous optic disc features, and visual field
defects consistent with assessed optic neuropathy. A diagnosis
Figure 1. PN pedigree chart with Pro370Leu myocilin mutation.
TABLE 1. THE SEQUENCES OF PRIMERS USED FOR MUTATION SCREENING OF MYOC.
Primer Primer sequence 5'→3' Product length (bp)
E1A TATTTTCTAAGAATCTTGCTGG  
  TGGATTCATTGGGACTGG 394
E1B GAAGCCTCACCAAGCCTC  
  GCCTGGTCCAAGGTCAAT 342
E1C CTGGAGGCCACCAAAGCT  
  AGAAAGGGCAGGCAGGGA 448
E2 CATAGTCAATCCTTGGGC  
  CTGCAGACCTGCTCTGACAA 392
E3A TTTCTGAATTTACCAGGATG  
  GTCAATGTCCGTGTAGCC 426
E3B CGGACAGTTCCCGTATTC  
  GCTTGGAGGCTTTTCACA 431
E3C CAAGACCCTGACCATCCC  
  TGCCCCAAATCACAAGAA 412
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1450of juvenile-onset open angle glaucoma (JOAG) was given
when patients were younger than 35 years at the time POAG
was diagnosed. If the person only exhibits an IOP above
21 mmHg (without IOP lowing therapy) in the absence of
damage  to  both  the  optic  nerve  and  the  visual  field,  that
individual will be diagnosed with ocular hypertension (OHT).
Topical medication was given to patients with IOPs higher
Figure 2. Optic disc photographs and Humphrey 30–2 visual fields
in affected patients who carry the Pro370Leu mutation.
than 21 mmHg. Patients whose IOPs could not be controlled
with medicine underwent combined trabeculectomy.
Linkage analysis: Peripheral blood leukocytes were obtained
from all available family members, including eight affected
and 14 unaffected individuals. Genomic DNA was isolated
from  peripheral  blood  according  to  standard  protocols.
Genotyping was performed with three microsatellite markers
(D1S3464,  D1S210,  and  D1S1619).  DNA  samples  were
subjected to polymerase chain reaction (PCR) amplification
using  primer  sequences  and  the  conditions  previously
described [9]. Briefly, DNA samples were performed in a 10
μl volume, containing 0.4 mM of each primer, 200 μM dNTPs,
1 U Taq DNA polymerase with a cycling profile of 30 cycles
at 94 °C for 30 s, 55 °C for 30 s, and 72 °C for 45 s. The PCR
products were separated on 5% denaturing polyacrylamide gel
in  an  Applied  Biosystems  377  DNA  sequencer  (Applied
Biosystems,  Foster  City,  CA).  Linkage  analysis  was
performed  by  calculating  two-point  LOD  scores  using
LINKAGE (ver. 5.1) software suite (provided in the public
domain by the Human Genome Mapping Project Resources
Center, Cambridge, UK).
Mutation  screening:  Primers  for  exons  and  exon-intron
boundaries were designed for MYOC (GenBank AB006686).
Primer sequences and their PCR product sizes are presented
in our previous paper [9] and presented in Table 1. Genomic
DNA (100 ng) was amplified in a GeneAmp PCR System
9700  (Applied  Biosystems)  with  conditions  previously
described  [9].  Briefly,  DNA  were  subjected  to  a  PCR
amplification with a protocol of 94 °C for 2 min, 30 cycles at
94 °C for 30 s, 55 °C~58 °C for 30 s, 72 °C for 30 s, and 72
°C  for  8  min.  The  amplified  exons  were  purified  and
sequenced  on  an  automated  DNA  sequencer  (model  377;
Applied Biosystems Inc.). All PCR products were sequenced
in both forward and reverse directions.
RESULTS
Clinical  phenotype  of  PN  pedigree:  According  to  the
distribution  of  the  affected  members  (Figure  1),  the  PN
pedigree is an autosomal dominant family with eight POAG
patients, account for 32% of all family members. Among the
affected  individuals,  four  are  male  and  four  are  female.
Patients II1, II2, and II3 were deceased at the time of our study,
but their medical records manifest their ocular disease. For the
patients with JOAG, the mean age at diagnosis was 17 years
(range  from  9  to  28  years)  and  the  mean  IOP  without
medication  was  34.18±2.97  mmHg  (ranged  from  29  to
40 mmHg). Examples of optic disc cupping and Humphrey
30–2 visual field defect are given for severe, intermediate, and
early cases in Figure 2. Most of the JOAG patients presented
poor  responsive  to  anti-glaucoma  medications.  Seven
individuals (87.5%) of the eight mutation carriers studied had
undergone glaucoma filtration surgery. All of the surgeries
were done at the Zhongshan Ophthalmic Center, Sun Yat-sen
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1452University  by  experienced  doctors.  After  the  surgery,  all
participants obtained their target IOP; none of them needed
any follow up anti-glaucoma medications. Only one patient
(V6)  was  still  receiving  medication  during  the  follow-up.
Maximum known IOP, age at diagnosis, and surgical status
of the affected individuals are given in Table 2.
Genotype of PN pedigree: By linkage analysis, two-point
LOD scores for D1S1619 and D1S210 were 2.59 (θ=0.0) and
1.63 (θ=0.0), respectively. These markers are located in close
vicinity to MYOC. Mutation analysis of this gene showed a
heterozygous C→T transition at the 1,109th nucleotide in
exon  3,  resulting  in  a  substitution  of  proline  for  leucine
(Pro370Leu) (Figure 3). The MYOC Pro370Leu mutation was
co-segregated among all affected individuals and was not
observed  in  unaffected  subjects.  Linkage  analysis  and
haplotype analysis demonstrated that all affected individuals
were heterozygous for this change (Figure 1).
DISCUSSION
The myocilin (MYOC) gene, the first detected causative gene
for  glaucoma,  is  located  on  chromosome  1q23-q24  and
encodes a secreted glycoprotein protein [4,5]. It has been
found that mutations in MYOC account for more than 10% of
dominant  juvenile  open-angle  glaucoma  cases  and
approximately 3% to 4% of unselected adult onset POAG
[10,11]. In this study, we described a Chinese family with
clinically diagnosed autosomal dominant juvenile-onset open
angle  glaucoma  (JOAG).  A  heterozygous  missense  C→T
mutation in exon 3 of MYOC was found in this family, co-
segregating with all glaucoma cases. According to the gene
sequence  of  myocilin,  a  polar  (proline)  amino  acid  was
replaced by a hydrophobic (leucine) amino acid due to the
C→T  transition  at  nucleotide  1109.  No  other  sequence
changes were detected in the entire coding region or splice
junctions of MYOC in this family.
As previously reported, most of the pedigrees linked to
Pro370Leu exhibited an earlier onset and more aggressive
glaucoma phenotype [12]. Thus the clinical features of the PN
pedigree were thoroughly assessed in our data. The age at
diagnosis of affected individuals ranged from 9 to 28 years
old (mean 17 years old). Without anti-glaucoma medication,
the  patients  with  mutation  presented  an  average  IOP  of
34.18±2.97 mmHg ranged from 29 to 40 mmHg. Most of the
patients required filtering surgery for long-term IOP control
because of the poor response to anti-glaucoma medications.
Therefore, it is confirmed that the PN pedigree also presents
a  JOAG  phenotype  with  an  early  age  of  onset,  rapid
progression  of  the  disease,  and  poor  response  to  medical
treatment.  The  phenotype  associated  with  Pro370Leu
correlates well with previous reports in other Chinese JOAG
pedigrees [12-16] (Table 3).
So far, mutations in MYOC are reported in POAG patients
by multiple research groups in different regions. According to
the  Myocilin  Allele-Specific  Glaucoma  Phenotype
Database, it has been shown that firm genotype–phenotype
correlations exist. The most prevalent Gln368Stop mutation
may give rise to milder POAG presentation with late onset
[17]. The Thr377Met mutation is associated with more severe
phenotype of the disease than Gln368Stop mutation [18,19].
The Pro370Leu, Gly246Arg, or Tyr437 His mutations are
responsible for the most severe glaucoma phenotypes with
early onset [20]. It is remarkable that the Pro370Leu mutation
has been found in patients of varying ethnicity, such as French,
English,  Indian,  North  American,  Japanese,  and  German
populations  [21-26].  In  Chinese  glaucoma  patients  or
pedigrees, 12 MYOC mutations have been identified, among
Figure  3.  DNA  sequence
chromatograms  of  the  Pro370Leu
MYOC mutation by DNA sequencing in
the PN pedigree.
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1454which Pro370Leu is the most frequently identified variant.
Because it is a prevalent and severe mutant allele both in
Chinese and in other ethnicities, further studies are required
to  clarify  the  pathogenic  roles  played  by  the  Pro370Leu
mutation in the pathogenesis of POAG with severe phenotype.
The molecular pathway from the glaucoma genotype to
the phenotype has not been elucidated. In accordance with
previous experiments by different laboratories, most evidence
supports  the  gain  of  function  theory  to  explain  the
pathogenesis  of  myocilin  glaucoma.  Studies  showed  that
mutant myocilin cannot be secreted in cultured cells; rather,
the mutant proteins were misfolded, and accumulated in the
endoplasmic reticulum (ER) as insoluble aggregates. This
aggregate may induce the procession of ER stress and lead to
potential cytotoxicity [27-30]. Furthermore, some important
evidence of genotype-phenotype correlation was revealed by
Aroca-Aguilar  et  al.  [31].  His  experiments  revealed  that
myocilin is proteolytically cleaved at the COOH-terminus of
Arg226  by  calpain  II.  Extended  study  found  that  the
endoproteolytic  processing  of  myocilin  was  inhibited  by
different mutations with varying efficiency. For instance, the
Pro370Leu led to the highest suppression of endoproteolytic
cleavage.  Meanwhile,  E323K  and  D380A  mutations
associated  with  milder  phenotypes  produce  less  intense
inhibition.  These  data  provide  more  clues  for  the  severe
disease-causing nature of the Pro370Leu allele.
According to the structure of myocilin, the Pro370Leu
transition occurs in the CpG dinucleotide region and also
within  the  highly  conserved  OLF-domain  [32].  It  was
hypothesized that a single amino acid change in the active
region of the protein may result in dramatic changes in the
predicted  secondary  structure.  The  severe  disease-causing
characteristics of Pro370Leu indicate that the change in the
structure  at  this  position  may  severely  affect  the  normal
processing of myocilin protein in cells, for instance in the
folding, conformation, interaction, cleavage, or secretion of
the  protein.  Therefore,  these  abnormalities  might  lead  to
cytotoxicity  of  the  trabecular  meshwork  cells  and  in  turn
impede the pathway of aqueous humor outflow. However, the
primary mechanism by which the variant causes JOAG has
not been fully unraveled and more events need to be explored.
To date, the frequencies of disease-causing mutations in
MYOC are similar to those of other ethnic groups (3.86% in
Caucasian patients, 3.30% in African patients, and 4.44% in
Asian  patients)  [33].  Considering  the  low  prevalence  of
MYOC-associated glaucoma, it is not feasible to screen whole
populations  for  mutations  [34].  Based  on  our  previous
research, we performed a prospective cohort study in a large
Chinese JOAG family (GZ.1 pedigree) with similar genotype
and phenotype to the PN pedigree. During the follow-up of 10
years,  all  Pro370Leu  carriers  in  the  GZ.1  pedigree  were
diagnosed  with  open-angle  glaucoma  [35].  These  results
provide evidence to prove that DNA screening is a useful
method  with  high  specificity  and  sensitivity  for  early
detection of the at-risk individual in a glaucoma pedigree.
Thus, gene screening can be used for pre-symptom diagnosis
and forewarning in familial open-angle glaucoma patients,
especially in pedigrees with early-onset.
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